

我們期待與您合作,并為您提供優質的服務。
產品系列
Commercial API Portfolio
Therapeutic Category |
Product Name |
DMF/GMP |
|
Antibacterial Sulfanilamide |
Sulfasalazine |
柳氮磺胺吡啶 |
CEP, Brazil, Korea |
Sulfadimethoxine |
磺胺間二甲氧嘧啶 |
USDMF, ASMF |
|
Sulfadimethoxine Sodium |
磺胺間二甲氧嘧啶鈉 |
USDMF, ASMF |
|
Antibiotic |
Meropenem |
美羅培南 |
JDMF |
Anticonvulsant |
Carbamazepine |
卡馬西平 |
USDMF, CEP, CADIFA, Korea, ANVISA GMP |
Oxcarbazepine |
奧卡西平 |
ASMF, NMPA DMF, USDMF |
|
Lacosamide |
拉考沙胺 |
NMPA DMF |
|
PD |
Rasagiline Mesylate |
甲磺酸雷沙吉蘭 |
NMPA DMF |
Antidiabetic |
Gliclazide |
格列齊特 |
CEP, JDMF, Canada, India, CADIFA |
Sitagliptin Hydrochloride |
鹽酸西格列汀 |
ASMF |
|
Sitagliptin Phosphate |
磷酸西格列汀 |
ASMF, USDMF, NMPA DMF |
|
Antihyperlipidemic |
Bezafibrate |
苯扎貝特 |
ASMF |
Non-Steroid Anti-Inflammatory |
Dexketoprofen Trometamol |
右旋酮洛芬氨丁三醇 |
ASMF, EUGMP |
Ketoprofen |
酮基布洛芬 |
CEP, JDMF, CADIFA, NMPA DMF, EUGMP |
|
Ketoprofen Lysinate |
酮基布洛芬賴氨酸鹽 |
ASMF, EUGMP |
|
Anti-Cancer |
Imatinib Mesylate |
甲磺酸伊馬替尼 |
CEP, USDMF, ASMF, NMPA DMF |
Axitinib |
阿西替尼 |
USDMF |
|
Gefitinib |
吉非替尼 |
CEP, USDMF, NMPA DMF |
|
Erlotinib Hydrochloride |
鹽酸厄洛替尼 |
NMPA DMF |
|
Antiviral |
Tenofovir Disoproxil Succinate |
琥珀酸替諾福韋二吡呋酯 |
ASMF |
Acyclovir |
阿昔洛韋 |
USDMF, CEP |
|
Antidepressant |
Venlafaxine Hydrochloride |
鹽酸文拉法辛 |
USDMF, CEP, NMPA DMF |
ED |
Sildenafil Citrate |
枸櫞酸西地那非 |
USDMF, CEP, NMPA DMF |
Antithrombin |
Cilostazol |
西洛他唑 |
NMPA DMF |
Anti-Hypertension |
Atenolol |
阿替洛爾 |
USDMF, CEP, JDMF |
Anti-SARS-CoV-2 |
*Nirmatrelvir |
奈瑪特韋 |
MPP License, WHO GMP |
Products under protection of valid patent are not offered to the countries where the patent law is in force. It's the buyer's responsibility and liability to check the patent situation in target market(s). Products should be developed for commercial use only in areas where the products have been registered and would not infringe any third party’s patents, otherwise products could only be used for research purpose. |